Question:
When is the JW modifier reported?
Answer:
For OPPS hospitals, reporting this modifier is required for all separately payable drugs assigned status indicators G (Pass-through Drugs and Biologicals) or K (Nonpass-through Drugs and Nonimplantable Biologicals, including Therapeutic Radiopharmaceuticals) when an unused or discarded amount is documented and submitted for reimbursement. When reporting both the administered volume of a drug as well as the discarded amount of a drug prepared from a single-dose vial or single-use package, providers are instructed to document the discarded drug or biological in the patient’s medical record.
CPT® copyright 2024 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
Copyright © 2025 RACmonitor. Powered by MedLearn Media.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24